The expression of p16 is regulated by the reversible histone acetylation

Progress in Biochemistry and Biophysics

Volumn 37, Issue 6, 2010, Pages 600-606

  Wang, Xiu Li ^a   Feng, Yun Peng ^a   Zhao, Jing ^a   Zhang, Guo Ping ^b   Pan, Hong ^a   Huang, Bai Qu ^a   Jun, L U ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

HDAC3; HDAC4; P16; P300; Reversible acetylation

Indexed keywords

EID: 77954891265     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2009.00722     Document Type: Article

References (28)

1. Kamb A, Gruis N A, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 1994, 264(5157): 436-440
2. Nobori T, Miura K, Wu D J, et al. Deletions of the cyclindependent kinase-4 inhibitor gene in multiple human cancers. Nature, 1994, 368(6473): 753-756 (Pubitemid 24153417)
3. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta, 1998, 1378(2): Fl 15-177 (Pubitemid 28530512)
4. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature, 1997, 389(6649): 349-352 (Pubitemid 27415209)
5. Cheung W L, Briggs S D, Allis C D. Acetylation and chromosomal functions. Curr Opin Cell Biol, 2000, 12(3): 326-333
6. Chan H M, La Thangue N B. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci, 2001, 114 (Pt3): 2363-2373
7. Buggy J J, Sideris M L, Mak P, et al. Cloning and characterization of a novel human histone deacetylase, HDAC8. Biochem J, 2000, 350(Pt1): 199-205
8. Verdel A, Khochbin S. Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation-dependent chromatin modifiers. J Biol Chem, 1999, 274(4): 2440-2445
9. Zhao X, Ito A, Kane C D, et al. The modular nature of histone deacetylase HDAC4 confers phosphorylation-dependent intracellular trafficking. J Biol Chem, 2001, 276(37): 35042-35048
10. Imai Y, Morita H, Kurihara H. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis, 2000, 149(2): 435-442 (Pubitemid 30145555)
11. Sherman J M, Stone E M, Freeman L L, et al. The conserved core of a human SIR2 homologue functions in yeast silencing. Mol Biol Cell, 1999, 10(9): 3045-3059
12. Wang X, Pan L, Feng Y, et al. p300 plays a role in p16(INK4a) expression and cell cycle arrest. Oncogene, 2008, 27(13): 1894-1904 (Pubitemid 351430815)
13. Wang X, Feng Y, Xu L, et al. YY1 restrained cell senescence through repressing the transcription of p16. Biochim Biophys Acta, 2008, 1783(10): 1876-1883
14. Feng Y, Wang X, Xu L, et al. The transcription factor ZBP-89 suppresses p16 expression through a histone modification mechanism to affect cell senescence. Febs J, 2009, 276(15): 4197-4206
15. Merchant J L, Iyer G R, Taylor B R, et al. ZBP-89, a Kruppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter. Mol Cell Biol, 1996, 16(12): 6644-6653
16. Boopathi E, Lenka N, Prabu S K, et al. Regulation of murine cytochrome c oxidase Vb gene expression during myogenesis: YY-1 and heterogeneous nuclear ribonucleoprotein D-like protein (JKTBP1) reciprocally regulate transcription activity by physical interaction with the BERF∼1/ZBP∼ 89 factor. J Biol Chem, 2004, 279(34): 35242-35254
17. Sun H, Lu J, Wei L, et al. Histone acetyltransferase activity of p300 enhances the activation of IL-12 p40 promoter. Mol Immunol, 2004, 41(12): 1241-1246 (Pubitemid 39346272)
18. Han S, Lu J, Zhang Y, et al. Recruitment of histone deacetylase 4 by transcription factors represses interleukin-5 transcription. Biochem J, 2006, 400(3): 439-448 (Pubitemid 44974455)
19. Zhao Y, Sun H, Lu J, et al. Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors. J Exp Biol, 2005, 208(Pt4): 697-705 (Pubitemid 40374513)
20. Lu J, Sun H, Wang X, et al. Interleukin-12 p40 promoter activity is regulated by the reversible acetylation mediated by HDAC1 and p300. Cytokine, 2005, 31(1): 46-51
21. Kondo Y, Shen L, Issa J P. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol, 2003, 23(1): 206-215 (Pubitemid 36008514)
22. Wang W, Wu J, Zhang Z, et al. Characterization of regulatory elements on the promoter region of p16(INK4a) that contribute to overexpression of pl6 in senescent fibroblasts. J Biol Chem, 2001, 276(52): 48655-48661
23. Law G L, Itoh H, Law D J, et al. Transcription factor ZBP-89 regulates the activity of the ornithine decarboxylase promoter. J Biol Chem, 1998, 273(32): 19955-19964 (Pubitemid 28377543)
24. Zhang X, Diab I H, Zehner Z E. ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator Spl. Nucleic Acids Res, 2003, 31(11): 2900-2914 (Pubitemid 37442134)
25. Ericsson J, Usheva A, Edwards PA. YY1 is a negative regulator of transcription of three sterol regulatory element-binding proteinresponsive genes. J Biol Chem, 1999, 274(20): 14508-14513
26. Van Lint C, Emiliani S, Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr, 1996, 5(4-5): 245-253
27. Matheu A, Klatt P, Serrano M. Regulation of the INK4a/ARF locus by histone deacetylase inhibitors. J Biol Chem, 2005, 280 (51): 42433-42441
28. Pellizzaro C, Coradini D, Daniotti A, et al. Modulation of cell cycle-related protein expression by sodium butyrate in human non-small cell lung cancer cell lines. Int J Cancer, 2001, 91(5): 654-657